-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, GIvoY6q0/la8Zqw7zqmOI9lZsAb/cuNs6qhmCo34RD7NUVvBsAcCvFXfsIAU0nW/ 4xKRKnpWihAUFd6BTSXv3g== 0001334971-09-000003.txt : 20091001 0001334971-09-000003.hdr.sgml : 20091001 20091001162104 ACCESSION NUMBER: 0001334971-09-000003 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: Rule 506 FILED AS OF DATE: 20091001 DATE AS OF CHANGE: 20091001 EFFECTIVENESS DATE: 20091001 FILER: COMPANY DATA: COMPANY CONFORMED NAME: CYTIMMUNE SCIENCES INC CENTRAL INDEX KEY: 0001334971 IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-79735 FILM NUMBER: 091098971 BUSINESS ADDRESS: STREET 1: 9640 MEDICAL CENTER DR CITY: ROCKVILLE STATE: MD ZIP: 20850 BUSINESS PHONE: 240-864-2791 MAIL ADDRESS: STREET 1: 9640 MEDICAL CENTER DR CITY: ROCKVILLE STATE: MD ZIP: 20850 D 1 primary_doc.xml X0603 D LIVE 0001334971 CYTIMMUNE SCIENCES INC 9640 MEDICAL CENTER DR ROCKVILLE MD 20850 240-864-2791 DELAWARE None None Corporation true Lawrence Tamarkin 9640 Medical Center Drive Rockville MD 20850 Executive Officer Director John W. Holaday 9640 Medical Center Drive Rockville MD 20850 Director Hidetaka Kentaro Itani 9640 Medical Center Drive Rockville MD 20850 Director Kenneth B. White 9640 Medical Center Drive Rockville MD 20850 Director Mitchell S. Marder 9640 Medical Center Drive Rockville MD 20850 Executive Officer Giulio F. Paciotti 9640 Medical Center Drive Rockville MD 20850 Executive Officer Jason Levine 9640 Medical Center Drive Rockville MD 20850 Executive Officer Biotechnology No Revenues 06 false 2009-09-18 false true true false 0 500000 500000 0 An outstanding $2,000,000 loan was extended beyond its original maturity date; a new $500,000 loan was issued; and warrants were provided to induce the lender to extend and enter into the loans. false 1 0 0 285000 true false CYTIMMUNE SCIENCES INC /s/ Mitchell S. Marder Mitchell S. Marder Executive VP, General Counsel and Secretary 2009-10-01 -----END PRIVACY-ENHANCED MESSAGE-----